Borviz 2.5 Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Bortezomib (2.5mg)
Overview Borviz 2.5 Injection
Bortezomib 2.5mg injection treats multiple myeloma and mantle cell lymphoma by inhibiting cancer cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be immediately apparent, requiring weeks or months; discontinue only under medical guidance. Common side effects include tiredness, nausea, vomiting, and decreased appetite. Increased fluid intake is often recommended. Operating machinery or driving should be avoided due to potential drowsiness and dizziness. This medication can lower blood cell counts, raising infection risk, necessitating regular blood tests monitoring blood cell levels, along with heart, liver function, and uric acid. Pre-existing liver, kidney, heart disease, or bleeding disorders require prior physician consultation. Report cognitive changes like memory loss or impaired thinking immediately. Inform your doctor of all other medications you're taking, as interactions are possible. Avoid conception during treatment; effective contraception for both partners is essential.
Uses of Borviz 2.5 Injection
Myeloma and mantle cell lymphoma
Major Benefits of Borviz 2.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Borviz 2.5 Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Borviz 2.5 Injection:
This medication will be administered by your healthcare provider; please do not self-medicate.
How Borviz 2.5 Injection works:
Borviz 2.5 Injection is a cancer treatment that inhibits the cellular breakdown of proteins. This protein accumulation within cancerous cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Borviz 2.5 Injection and alcohol may result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Borviz 2.5 Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Borviz 2.5 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Borviz 2.5 Injection may induce adverse reactions impacting driving capabilities. These reactions can include fatigue, vertigo, syncope, or visual disturbances, potentially impairing the ability to operate a vehicle.
KidneyCAUTION
Patients with severe renal impairment should use Borviz 2.5 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Borviz 2.5 Injection judiciously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Borviz 2.5 Injection :
Omit a Borviz 2.5 Injection dose? Seek medical advice immediately.
Facts to Know About Borviz 2.5 Injection
| Label | Value |
|---|---|
| Chemical Category | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Type of Treatment | Cancer Medications |
3,018 People bought this recently